ACTU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Actuate Therapeutics Inc (ACTU) is not a good buy for a beginner, long-term investor at this time. The stock lacks positive catalysts, shows weak financial performance, and has no strong trading signals or favorable technical indicators to justify immediate investment.
The MACD is slightly positive, but the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 2.222 and resistance at 2.471. Overall, the technical indicators suggest a bearish trend.
NULL identified. No recent news or significant insider/hedge fund activity.
The stock has a 60% chance of declining by -2.91% in the next week. Financial performance shows a significant drop in net income (-29.35% YoY) and EPS (-38.71% YoY).
In Q4 2025, the company reported zero revenue growth, a net income drop of -29.35% YoY, and an EPS decline of -38.71% YoY. Gross margin remains at 0, indicating no profitability.
No analyst ratings or price target changes available.
